Cargando…
The increasing need for biomarkers in intensive care unit-acquired weakness - are microRNAs the solution?
There is an increasing focus on intensive care unit-acquired weakness, its underlying mechanisms and therapeutic options. In this article we offer a commentary on the paper by Bloch and colleagues entitled 'MiR-181a: a potential biomarker of acute muscle wasting following cardiac surgery'....
Autores principales: | Lugg, Sebastian T, Howells, Phillip A, Thickett, David R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406039/ https://www.ncbi.nlm.nih.gov/pubmed/25902802 http://dx.doi.org/10.1186/s13054-015-0901-1 |
Ejemplares similares
-
Optimal Vitamin D Supplementation Levels for Cardiovascular Disease Protection
por: Lugg, Sebastian T., et al.
Publicado: (2015) -
Intensive care unit acquired muscle weakness: when should we consider rehabilitation?
por: Puthucheary, Zudin, et al.
Publicado: (2009) -
MicroRNAs and senescence
por: Martinez, Ivan, et al.
Publicado: (2011) -
A stronger approach to weakness in the intensive care unit
por: Young, G Bryan, et al.
Publicado: (2004) -
microRNAs in viral oncogenesis
por: Scaria, Vinod, et al.
Publicado: (2007)